Literature DB >> 14995277

Renormalized random walk study of oxygen absorption in the human lung.

M Felici1, M Filoche, B Sapoval.   

Abstract

The possibility to renormalize random walks is used to study numerically the oxygen diffusion and permeation in the acinus, the diffusion cell terminating the mammalian airway tree. This is done in a 3D tree structure which can be studied from its topology only. The method is applied to the human acinus real morphology as studied by Haefeli-Bleuer and Weibel in order to compute the respiratory efficiency of the human lung. It provides the first quantitative evidence of the role of diffusion screening in real 3D mammalian respiration. The net result of this study is that, at rest, the efficiency of the human acinus is only of order 33%. Application of these results to CO2 clearance provides for the first time a theoretical support to the empirical relation between the O2 and CO2 partial pressures in blood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14995277     DOI: 10.1103/PhysRevLett.92.068101

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  4 in total

1.  Theoretical analysis of the determinants of lung oxygen diffusing capacity.

Authors:  Tuhin K Roy; Timothy W Secomb
Journal:  J Theor Biol       Date:  2014-02-20       Impact factor: 2.691

2.  Reverse engineering of oxygen transport in the lung: adaptation to changing demands and resources through space-filling networks.

Authors:  Chen Hou; Stefan Gheorghiu; Virginia H Huxley; Peter Pfeifer
Journal:  PLoS Comput Biol       Date:  2010-08-26       Impact factor: 4.475

Review 3.  Lung Structure and the Intrinsic Challenges of Gas Exchange.

Authors:  Connie C W Hsia; Dallas M Hyde; Ewald R Weibel
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

4.  Trapping in and Escape from Branched Structures of Neuronal Dendrites.

Authors:  Robin Jose; Ludger Santen; M Reza Shaebani
Journal:  Biophys J       Date:  2018-10-04       Impact factor: 4.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.